Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Nymox Pharmaceutical Corporation Nymox Annual Report July 18, 2024 From Nymox Pharmaceutical Corporation Via GlobeNewswire Tickers NYMXF Nymox Required to Resubmit Application to DKMA July 16, 2024 From Nymox Pharmaceutical Corporation Via GlobeNewswire Tickers NYMXF Nymox Reports Victory in Bahamas Litigation Against Terminated Ex-Employees – Court Awards Costs and Damages March 27, 2024 From Nymox Pharmaceutical Corporation Via GlobeNewswire Tickers NYMXF Nymox December 27 Message to Shareholders December 27, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire Tickers NYMXF Nymox Reports California Court Issues Preliminary Injunction Against Defendants Lanham, Riley, Cutler and Others November 30, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire Tickers NYMXF $250 Million Lawsuit Filed Against AscellaHealth by Nymox Accepted and Summons Issued in California Court November 21, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire Tickers NYMXF Nymox Pharmaceutical Corporation Sues AscellaHealth For $250 Million November 09, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire Tickers NYMXF NYMOX REPORTS: Bahamian Court Today Suspends Order of October 3, 2023 Rendering Riley-Lanham and Accomplices Planned Vote Unauthorized November 03, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire Tickers NYMXF NYMOX REPORTS NOTICE: California Court Issued A Temporary Restraining Order Enjoining Lanham, Riley, Cutler And Their Nevada Company After Court Hearing In Santa Ana, California, November 2, 2023 November 03, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire Tickers NYMXF IMPORTANT MESSAGE TO NYMOX SHAREHOLDERS: NYMOX Cautions Against Unauthorized Improper Shareholder Meeting and Unauthorized Unregistered Solicitations November 02, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire Tickers NYMXF IMPORTANT NOTICE: NYMOX Cautions Shareholders Not to Take Calls or Participate in Unauthorized Improper Shareholder Meeting October 31, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire Tickers NYMXF Notice: Nymox Informs Its Shareholders Not to Take Calls or Participate in An Unauthorized and Improper Shareholder Meeting October 27, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire Tickers NYMXF Nymox Reports New NYMOZARFEX Marketing Application is Accepted For Review October 26, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire Tickers NYMXF Nymox Announces Submission of New Marketing Authorization Application Submission for NYMOZARFEX (TM) for BPH September 25, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire Tickers NYMXF Nymox Reports Completion of $2 Million Private Placement August 29, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire Tickers NYMXF Nymox Announces $2 Million Private Placement August 02, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire Tickers NYMXF Nymox's 3-month ex-CFO was Awarded an Unauthorized and Undisclosed Treasury Directive for 100,000 Shares of Nymox Stock Without the Knowledge or Approval of the Nymox Board or Nymox’s CEO July 31, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire Tickers NYMXF Nymox Reports Successful New NYMOZARFEX (TM) Long-Term Prostate Cancer Treatment Clinical Trial Results July 25, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire Tickers NYMX Nymox Reports on U.S. Patent Issuances July 18, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire Tickers NYMX Nymox Update July 13, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire Tickers NYMX Nymox Announces Appointment Of Patrick Doody as Vice President and Member of the Board of Directors of Nymox July 12, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire Tickers NYMX NYMOX Update July 07, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire Tickers NYMX Nymox Delisting from NASDAQ July 05, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire Tickers NYMX Nymox Provides Current Update May 10, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire Tickers NYMX Nymox Provides Corporate Update April 03, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire Tickers NYMX Nymox Announces Appointment of Christopher R. Riley as Chief Financial Officer March 21, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire Tickers NYMX Nymox Officially Granted Extension to Regain Listing Requirements March 15, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire Tickers NYMX Nymox Announces NYMOZARFEX Marketing Application is Accepted For Review February 15, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire Tickers NYMX NYMOX Appeals Deficiency Letter January 06, 2023 From Nymox Pharmaceutical Corporation Via GlobeNewswire Tickers NYMX NYMOX Announces New Marketing Submission for NYMOZARFEX™ for BPH December 05, 2022 From Nymox Pharmaceutical Corporation Via GlobeNewswire Tickers NYMX Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.